Carmen Fierbinteanu-Braticevici

Summary

Publications

  1. ncbi request reprint The effect of valsartan, an angiotensin II receptor antagonist, on portal and systemic hemodynamics and on renal function in liver cirrhosis
    Carmen Fierbinteanu-Braticevici
    2nd Medical Clinic Gastroenterology, University Hospital, Splaiul Independentei no 169, Bucharest, Romania
    J Gastrointestin Liver Dis 15:337-42. 2006
  2. ncbi request reprint The role of octreotide on renal function in patients with advanced cirrhosis
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II, Department of Gastroenterology, University Hospital Bucharest, Romania
    Rom J Intern Med 42:173-81. 2004
  3. ncbi request reprint Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease
    Carmen Fierbinteanu Braticevici
    Carol Davila University of Medicine and Pharmacy, II Medical Clinic and Gastroenterology, University Hospital Bucharest, Bucharest, Romania Electronic address
    Ultrasound Med Biol 39:1942-50. 2013
  4. ncbi request reprint The role of ¹³C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease
    Carmen Fierbinteanu-Braticevici
    Carol Davila University of Medicine and Pharmacy, Medical Clinic II and Gastroenterology, University Hospital Bucharest, Romania
    J Gastrointestin Liver Dis 22:149-56. 2013
  5. ncbi request reprint Is fatty liver always benign and should not consequently be treated?
    C Fierbinteanu-Braticevici
    Carol Davila University of Medicine and Pharmacy, Medical Clinic II and Gastroenterology, University Hospital Bucharest, Romania
    J Physiol Pharmacol 64:3-9. 2013
  6. ncbi request reprint Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II and Gastroenterology, University Hospital Bucharest, Bucharest, Romania
    J Gastrointestin Liver Dis 20:153-9. 2011
  7. pmc Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II and Gastroenterology, University Hospital Bucharest, 7001 Bucharest, Romania
    World J Gastroenterol 16:4784-91. 2010
  8. ncbi request reprint Hepatocyte steatosis in patients infected with genotype 1 hepatitis C virus
    Carmen Fierbinteanu-Braticevici
    2nd Medical Clinic Gastroenterology, University Hospital Bucharest, Romania
    Rom J Morphol Embryol 51:235-42. 2010
  9. pmc Non-biopsy methods to determine hepatic fibrosis
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II and Gastroenterology, University Hospital Bucharest, Romania
    J Med Life 2:401-6. 2009
  10. pmc Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II and Gastroenterology, University Hospital, Bucharest, Romania
    World J Gastroenterol 15:5525-32. 2009

Detail Information

Publications15

  1. ncbi request reprint The effect of valsartan, an angiotensin II receptor antagonist, on portal and systemic hemodynamics and on renal function in liver cirrhosis
    Carmen Fierbinteanu-Braticevici
    2nd Medical Clinic Gastroenterology, University Hospital, Splaiul Independentei no 169, Bucharest, Romania
    J Gastrointestin Liver Dis 15:337-42. 2006
    ..The aim of the study was to assess the effects of valsartan, a new generation angiotensin II receptor antagonist, on portal and systemic hemodynamics and on renal function in cirrhosis...
  2. ncbi request reprint The role of octreotide on renal function in patients with advanced cirrhosis
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II, Department of Gastroenterology, University Hospital Bucharest, Romania
    Rom J Intern Med 42:173-81. 2004
    ..The aim of our study was to assess the effects on renal hemodynamics by the administration of octreotide, the synthetic somatostatin analog, an inhibitor of the release of endogenous vasodilatators...
  3. ncbi request reprint Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease
    Carmen Fierbinteanu Braticevici
    Carol Davila University of Medicine and Pharmacy, II Medical Clinic and Gastroenterology, University Hospital Bucharest, Bucharest, Romania Electronic address
    Ultrasound Med Biol 39:1942-50. 2013
    ..984). In conclusion, ARFI elastography is a promising method for differentiating patients with non-alcoholic steatohepatitis from patients with simple steatosis and can also predict significant fibrosis in these patients. ..
  4. ncbi request reprint The role of ¹³C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease
    Carmen Fierbinteanu-Braticevici
    Carol Davila University of Medicine and Pharmacy, Medical Clinic II and Gastroenterology, University Hospital Bucharest, Romania
    J Gastrointestin Liver Dis 22:149-56. 2013
    ..The aim of our study was to evaluate the efficacy of MBT in differentiating patients with non-alcoholic steatohepatitis (NASH) from patients with simple steatosis (SS) and its ability to predict significant fibrosis in NAFLD patients...
  5. ncbi request reprint Is fatty liver always benign and should not consequently be treated?
    C Fierbinteanu-Braticevici
    Carol Davila University of Medicine and Pharmacy, Medical Clinic II and Gastroenterology, University Hospital Bucharest, Romania
    J Physiol Pharmacol 64:3-9. 2013
    ..We tried to shed some light on this problem, taking into account its major health impact and the variegate and sometimes unpredictable evolution of NAFLD...
  6. ncbi request reprint Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD)
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II and Gastroenterology, University Hospital Bucharest, Bucharest, Romania
    J Gastrointestin Liver Dis 20:153-9. 2011
    ..The aim of our study was to assess the clinical and biological parameters associated with Nonalcoholic steatohepatitis (NASH) and to establish the predictors of significant fibrosis in Nonalcoholic fatty liver disease (NAFLD) patients...
  7. pmc Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II and Gastroenterology, University Hospital Bucharest, 7001 Bucharest, Romania
    World J Gastroenterol 16:4784-91. 2010
    ..Tissue polypeptide specific antigen seems to have a clinical utility in the follow-up of obese patients with NASH...
  8. ncbi request reprint Hepatocyte steatosis in patients infected with genotype 1 hepatitis C virus
    Carmen Fierbinteanu-Braticevici
    2nd Medical Clinic Gastroenterology, University Hospital Bucharest, Romania
    Rom J Morphol Embryol 51:235-42. 2010
    ..Both host and viral factors contribute to the development of steatosis in chronic hepatitis C. Steatosis is an initial stage, which promotes hepatic fibrosis through oxidative stress...
  9. pmc Non-biopsy methods to determine hepatic fibrosis
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II and Gastroenterology, University Hospital Bucharest, Romania
    J Med Life 2:401-6. 2009
    ..The purpose of this article is to present the noninvasive evaluation of patients with chronic liver disease as an alternative of liver biopsy in the assessment of hepatic structure and function...
  10. pmc Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II and Gastroenterology, University Hospital, Bucharest, Romania
    World J Gastroenterol 15:5525-32. 2009
    ..To investigate the diagnostic accuracy of acoustic radiation force impulse (ARFI) imaging as a noninvasive method for the assessment of liver fibrosis in chronic hepatitis C (CHC) patients...
  11. ncbi request reprint Role of oxidative stress in the pathogenesis of chronic hepatitis C (CHC)
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II and Gastroenterology, University Emergency Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
    Rom J Morphol Embryol 50:407-12. 2009
    ..The induction of GGT is an adaptive response against oxidative damage elicited by lipid peroxidation and it may be critical in the progression of the disease...
  12. ncbi request reprint Portal hypertensive gastropathy
    L Negreanu
    Internal Medicine and Gastroenterology Clinic, University Hospital, Bucharest, Romania
    Rom J Intern Med 43:3-8. 2005
    ..Current therapy of PHG includes beta blockers, somatostatin and derivates, endoscopic and surgical methods including hepatic transplantation...
  13. ncbi request reprint The risk factors of fibrosis in nonalcoholic steatohepatitis
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II, University Hospital, 169, Splaiul Independentei, Bucharest, Romania
    Rom J Intern Med 40:81-8. 2002
    ..Nonalcoholic steatohepatitis (NASH) can be a severe progressive liver disease leading to the development of cirrhosis. The aim of this study was to assess the risk factors of fibrosis in NASH...
  14. ncbi request reprint HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C
    Mircea Grigorescu
    University of Medicine and Pharmacy Iuliu Hatieganu, Clinical Emergency Hospital Professor Dr Octavian Fodor, Cluj Napoca, Romania
    J Gastrointestin Liver Dis 18:45-50. 2009
    ....
  15. ncbi request reprint The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis
    Carmen Fierbinteanu-Braticevici
    Medical Clinic II, Department of Gastroenterology, University Hospital, Bucharest, Romania
    Rom J Intern Med 41:247-54. 2003
    ..Portal hypertension is the result of increased hepatic resistance and portal influx...